Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × ofatumumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 26 Leukemia, B-Cell 10 Lymphoma 7 Leukemia 7 Recurrence 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Neoplasms 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Waldenstrom Macroglobulinemia 3 Burkitt Lymphoma 3 Thrombocytopenia 1 Paraproteinemias 1 Oncology Patients Receiving Chemotherapy 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphocytosis 1 Lymphadenopathy 1 Leukemia, Prolymphocytic 1 Leukemia, Lymphoid 1 Fever 1 Fatigue 1 Bronchiolitis Obliterans Syndrome 1 Agammaglobulinemia 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡